These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 1931628

  • 1. A prospective randomised trial of radiation with or without oral and intravesical misonidazole for bladder cancer.
    Abratt RP, Craighead P, Reddi VB, Sarembock LA.
    Br J Cancer; 1991 Nov; 64(5):968-70. PubMed ID: 1931628
    [Abstract] [Full Text] [Related]

  • 2. Radical radiation and oral and intra-vesical misonidazole for bladder cancer.
    Abratt RP, Barnes DR, Pontin AR, Sarembock LA, Williams AM.
    Int J Radiat Oncol Biol Phys; 1987 Jul; 13(7):1053-5. PubMed ID: 3597148
    [Abstract] [Full Text] [Related]

  • 3. Radical irradiation and misonidazole for T2 grade III and T3 bladder cancer: 2 year follow-up.
    Abratt RP, Barnes DR, Hammond JA, Sarembok LA, Tucker RD, Williams AM.
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1719-20. PubMed ID: 6384160
    [Abstract] [Full Text] [Related]

  • 4. Radical irradiation and misonidazole in the treatment of T2 grade III and T3 bladder cancer.
    Abratt RP, Sealy R, Tucker RD, Williams MA, Barnes DR, Johnson MB, Green JA, Cridland JS.
    Int J Radiat Oncol Biol Phys; 1983 May; 9(5):629-32. PubMed ID: 6853264
    [Abstract] [Full Text] [Related]

  • 5. Effect of misonidazole in preoperative irradiation for bladder cancer followed by total cystectomy.
    Ono K, Akuta K, Takahashi M, Abe M, Nishio Y, Okada K, Yoshida O.
    Radiat Med; 1989 May; 7(2):105-9. PubMed ID: 2508190
    [Abstract] [Full Text] [Related]

  • 6. Radiotherapy with or without misonidazole for patients with stage IIIB or stage IVA squamous cell carcinoma of the uterine cervix: preliminary report of a Radiation Therapy Oncology Group randomized trial.
    Leibel S, Bauer M, Wasserman T, Marcial V, Rotman M, Hornback N, Cooper J, Gillespie B, Pakuris E, Conner N.
    Int J Radiat Oncol Biol Phys; 1987 Apr; 13(4):541-9. PubMed ID: 3104249
    [Abstract] [Full Text] [Related]

  • 7. Misonidazole in the preoperative and radical radiotherapy of bladder cancer.
    Awwad HK, El Merzabani MM, El Badawy S, Ezzat S, Akoush H, Abd El Moneim H, Saiid A, Soliman O, Khafagy M, Burgers MV.
    Cancer Clin Trials; 1980 Apr; 3(3):275-80. PubMed ID: 7438324
    [Abstract] [Full Text] [Related]

  • 8. A randomised trial of accelerated radiotherapy for localised invasive bladder cancer.
    Horwich A, Dearnaley D, Huddart R, Graham J, Bessell E, Mason M, Bliss J.
    Radiother Oncol; 2005 Apr; 75(1):34-43. PubMed ID: 15878099
    [Abstract] [Full Text] [Related]

  • 9. Positive clinical experience with misonidazole in brachytherapy and external radiotherapy.
    Baillet F, Housset M, Dessard-Diana B, Boisserie G.
    Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1073-5. PubMed ID: 2703387
    [Abstract] [Full Text] [Related]

  • 10. A phase I/II study of the hypoxic cell sensitizer misonidazole as an adjunct to high fractional dose radiotherapy in patients with unresectable squamous cell carcinoma of the head and neck: a RTOG randomized study (#79-04).
    Lee DJ, Pajak TF, Stetz J, Order SE, Weissberg JB, Fischer JJ.
    Int J Radiat Oncol Biol Phys; 1989 Feb; 16(2):465-70. PubMed ID: 2646255
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Bladder cancer. The selection of patients for treatment by full-dose irradiation.
    Shipley WU, Rose MA.
    Cancer; 1985 May 01; 55(9 Suppl):2278-84. PubMed ID: 3919933
    [Abstract] [Full Text] [Related]

  • 13. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
    George L, Bladou F, Bardou VJ, Gravis G, Tallet A, Alzieu C, Serment G, Salem N.
    Urology; 2004 Sep 01; 64(3):488-93. PubMed ID: 15351577
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Bladder preservation by combined modality therapy for invasive bladder cancer.
    Kachnic LA, Kaufman DS, Heney NM, Althausen AF, Griffin PP, Zietman AL, Shipley WU.
    J Clin Oncol; 1997 Mar 01; 15(3):1022-9. PubMed ID: 9060542
    [Abstract] [Full Text] [Related]

  • 16. Induction cisplatin and fluorouracil-based chemotherapy followed by concurrent chemoradiation for muscle-invasive bladder cancer.
    Lin CC, Hsu CH, Cheng JC, Huang CY, Tsai YC, Hsu FM, Huang KH, Cheng AL, Pu YS.
    Int J Radiat Oncol Biol Phys; 2009 Oct 01; 75(2):442-8. PubMed ID: 19307067
    [Abstract] [Full Text] [Related]

  • 17. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.
    Gofrit ON, Shapiro A, Pode D, Sidi A, Nativ O, Leib Z, Witjes JA, van der Heijden AG, Naspro R, Colombo R.
    Urology; 2004 Mar 01; 63(3):466-71. PubMed ID: 15028439
    [Abstract] [Full Text] [Related]

  • 18. A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery: final report of an RTOG study.
    Nelson DF, Diener-West M, Weinstein AS, Schoenfeld D, Nelson JS, Sause WT, Chang CH, Goodman R, Carabell S.
    Int J Radiat Oncol Biol Phys; 1986 Oct 01; 12(10):1793-800. PubMed ID: 3531110
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Experience in the radical radiotherapy of cancer in the bilharzial bladder: the use of misonidazole.
    Awwad HK, Akhoush H, El-Merzabani M, El Badawy S, Barsoum M, el Baki HA.
    Radiother Oncol; 1984 Jun 01; 2(1):1-8. PubMed ID: 6095372
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.